Result: One participant infected through heterosexual contact harbored dual mutations in
NRTIs (
T69N,
M184V, and
T215Y) and
NNRTIs (
K103N and
M230L), and presented with high-level resistance to lamivudine (3TC) and emtricitabine (FTC) with
M184V, intermediate-level resistance to zidovudine (AZT) and stavudine (D4T) with
T215Y, and intermediate or high-level resistance to all
NNRTIs with
K103N and
M230L.